Drugplain

Gomekli 1 mg/1

mirdametinib · CAPSULE · SpringWorks Therapeutics, Inc.

No Recall History
Plain English

Gomekli is a capsule containing mirdametinib at 1 mg/1, taken oral. Manufactured by SpringWorks Therapeutics, Inc..

Key Facts

Brand Name
Gomekli
Generic Name
mirdametinib
NDC Code (Product)
82448-130
Manufacturer
SpringWorks Therapeutics, Inc.
Strength
1 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA219389
Drug Class
Kinase Inhibitor [EPC]
Marketing Start
02/11/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

rash23 reports
nausea15 reports
fatigue13 reports
pain12 reports
acne10 reports
alopecia9 reports
dermatitis acneiform9 reports
gastrointestinal disorder8 reports
dehydration7 reports
diarrhoea7 reports

Frequently Asked Questions

What is Gomekli used for?

Gomekli contains mirdametinib. It is a capsule taken oral. Consult your doctor for specific uses.

Is Gomekli a controlled substance?

Gomekli is not classified as a controlled substance by the DEA.

What is the generic name for Gomekli?

The generic name for Gomekli is mirdametinib. There are no other listed brand versions of mirdametinib.

What is the NDC code for Gomekli 1 mg/1?

The NDC (National Drug Code) for Gomekli 1 mg/1 is 82448-130, listed by SpringWorks Therapeutics, Inc..

Product NDC

82448-130

Package NDC

82448-130-42

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)